Skip Nav Destination
Issues
15 April 2000
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Review
Advances in Brief
Regulation of TCL1 Expression in B- and T-Cell Lymphomas and Reactive Lymphoid Tissues1
Maria Grazia Narducci; Edoardo Pescarmona; Cristina Lazzeri; Sabina Signoretti; Anna Maria Lavinia; Daniele Remotti; Enrico Scala; Carlo David Baroni; Antonella Stoppacciaro; Carlo Maria Croce; Giandomenico Russo
Biochemistry and Biophysics
Clinical Investigations
Complete Sequencing of TP53 Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer1
Els M. J. J. Berns; John A. Foekens; Rolf Vossen; Maxime P. Look; Peter Devilee; Sonja C. Henzen-Logmans; Iris L. van Staveren; Wim L. J. van Putten; Mats Inganäs; Marion E. Meijer-van Gelder; Cees Cornelisse; Cassandra J. C. Claassen; Henk Portengen; Bert Bakker; Jan G. M. Klijn
Endocrinology
Experimental Therapeutics
PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration
Jeanette M. Wood; Guido Bold; Elizabeth Buchdunger; Robert Cozens; Stefano Ferrari; Jörg Frei; Francesco Hofmann; Jürgen Mestan; Helmut Mett; Terence O’Reilly; Elke Persohn; Johannes Rösel; Christian Schnell; David Stover; Andreas Theuer; Harry Towbin; Fritz Wenger; Kathie Woods-Cook; Andreas Menrad; Gerhard Siemeister; Michael Schirner; Karl-Heinz Thierauch; Martin R. Schneider; Joachim Drevs; Georg Martiny-Baron; Frank Totzke; Dieter Marmé
Immunology
CC Chemokine Receptor-7 on Dendritic Cells Is Induced after Interaction with Apoptotic Tumor Cells: Critical Role in Migration from the Tumor Site to Draining Lymph Nodes1
Motohiro Hirao; Nobuyuki Onai; Kazumasa Hiroishi; Simon C. Watkins; Kouji Matsushima; Paul D. Robbins; Michael T. Lotze; Hideaki Tahara
Immune Deviation and Fas-mediated Deletion Limit Antitumor Activity after Multiple Dendritic Cell Vaccinations in Mice1
Antoni Ribas; Lisa H. Butterfield; Billy Hu; Vivian B. Dissette; Wilson S. Meng; Andrew Koh; Kahlil J. Andrews; Maggie Lee; Saral N. Amar; John A. Glaspy; William H. McBride; James S. Economou
Molecular Biology and Genetics
Tumor Biology
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.